Aucta Pharmaceuticals, LLC — Department of Health and Human Services SBIR Phase I: To support the development of pediatric oral formulations for the anti-TB drugs isoniazid
Aucta Pharmaceuticals, LLC — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $224,284
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- NAICS
- —
- Place of performance
- NJ
- Period
- —
Description
To support the development of pediatric oral formulations for the anti-TB drugs isoniazid and streptomycin through various chemical processes. PUBLIC HEALTH RELEVANCE